These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 863579)
1. Organ distribution of 99mTc-labelled aminethiols. Zalutsky M; Sullivan JC; Friedman AM; Rayudu GV; Deutsch E Int J Nucl Med Biol; 1977 Jan; 4(1):53-6. PubMed ID: 863579 [No Abstract] [Full Text] [Related]
2. Chemical and biological studies on 99mTc-DMS--I: Formation of complexes by four different methods. Ikeda I; Inoue O; Kurata K Int J Nucl Med Biol; 1977 Jan; 4(1):56-65. PubMed ID: 863580 [No Abstract] [Full Text] [Related]
3. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA). Westera G; Gadze A; Horst W Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143 [TBL] [Abstract][Full Text] [Related]
4. Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells. Verbeke KA; Vanbilloen HP; De Roo MJ; Verbruggen AM Eur J Nucl Med; 1993 Jun; 20(6):473-82. PubMed ID: 8339730 [TBL] [Abstract][Full Text] [Related]
6. [The development of new tumor imaging 99mTc (V)-DMS kit: preparation and labeling condition studies]. Yomoda I; Horiuchi K; Hata N; Masuda H; Yokoyama A; Ogawa H; Nakazawa N; Ooi T Kaku Igaku; 1987 Jan; 24(1):77-82. PubMed ID: 3033361 [No Abstract] [Full Text] [Related]
7. The preparation and control of pyrrolidino-methyl tetracycline labelled with 99mTc. Zmbova B; Zivanov-Stakić D; Tadzer I; Bogdanova V Int J Appl Radiat Isot; 1978 Jun; 29(6):359-62. PubMed ID: 750498 [No Abstract] [Full Text] [Related]
8. 99mTc(Sn) phosphocreatine: labeling characteristics and biological distribution. Castronovo FP; Deluca SA; Potsaid MS Int J Appl Radiat Isot; 1976 Feb; 27(2):93-6. PubMed ID: 1254348 [No Abstract] [Full Text] [Related]
10. 99mTc-labelled compounds prepared with molybdenum III as reducing agent. Vilcek S; Machán V; Kalincák M Int J Appl Radiat Isot; 1984 Mar; 35(3):228-30. PubMed ID: 6425226 [TBL] [Abstract][Full Text] [Related]
11. Preparation of technetium-99-DMS renal complex in solution and its chemical and biological characterization. Vanlić-Razumenić N; Petrović J Int J Appl Radiat Isot; 1982 Apr; 33(4):277-84. PubMed ID: 6282761 [TBL] [Abstract][Full Text] [Related]
12. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules. Wang Y; Liu G; Hnatowich DJ Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438 [TBL] [Abstract][Full Text] [Related]
13. 99mTc-labelled liposomes preparation of radiopharmaceutical and its distribution in a hepatoma patient. Richardson VJ; Ryman BE; Jewkes RF; Tattersall MH; Newlands ES Int J Nucl Med Biol; 1978; 5(2-3):118, 121-2, 123. PubMed ID: 222703 [No Abstract] [Full Text] [Related]
14. First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer. Verbeke KA; Vanhecke WB; Mortelmans LA; Verbruggen AM Eur J Nucl Med; 1994 Sep; 21(9):906-12. PubMed ID: 7995283 [TBL] [Abstract][Full Text] [Related]
18. A new radiopharmaceutical for gallbladder studies: 99mTc-Sn-LIDA complex. Subramian G; Chander J; Singh MV; Dham DN; Lakshmipathi N; Singh B Nuklearmedizin; 1977 Apr; 16(2):83-5. PubMed ID: 876847 [TBL] [Abstract][Full Text] [Related]
19. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. I: Radiochemical and animal distribution studies. Galli G; Maini CL; Orlando P; Deleide G; Valle G J Nucl Med Allied Sci; 1988; 32(2):110-6. PubMed ID: 3049961 [No Abstract] [Full Text] [Related]
20. Basic studies of various 99mTc-labelled renal agents and clinical application of 99mTc-malate. Machida T; Miki M; Ueda M; Tanaka A; Ikeda I Nuklearmedizin; 1977 Feb; 16(1):36-41. PubMed ID: 846865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]